CLL14: venetoclax-obinutuzumab improves PFS and MRD in untreated, reduced fitness CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:16 5 years ago 280 Далее Скачать
Venetoclax plus obinutuzumab improves PFS and MRD-negativity in patients with previously untreat... ecancer 10:45 5 years ago 103 Далее Скачать
Six-year update from CLL14: fixed-duration venetoclax + obinutuzumab for previously untreated CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:43 1 year ago 296 Далее Скачать
CLL14 trial thoughts VJHemOnc – Video Journal of Hematology & HemOnc 1:14 5 years ago 99 Далее Скачать
CLL14: Venetoclax plus obinutuzumab for CLL VJHemOnc – Video Journal of Hematology & HemOnc 5:54 3 years ago 983 Далее Скачать
6-year results of CLL14: venetoclax-obinutuzumab for previously untreated CLL VJHemOnc – Video Journal of Hematology & HemOnc 5:59 1 year ago 2 019 Далее Скачать
Fixed-duration therapy with venetoclax-obinutuzumab in frontline CLL VJHemOnc – Video Journal of Hematology & HemOnc 10:24 5 years ago 1 736 Далее Скачать
Venetoclax and obinutuzumab combination therapy for CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:03 5 years ago 602 Далее Скачать
CLL14 trial analysis VJHemOnc – Video Journal of Hematology & HemOnc 3:07 5 years ago 595 Далее Скачать
CLL14 trial: do certain patients benefit more from venetoclax plus obinutuzumab in CLL? Lymphoma Hub 3:08 5 years ago 586 Далее Скачать
5-year follow-up results of CLL14: obinutuzumab + venetoclax vs obinutuzumab + chlorambucil in CLL VJHemOnc – Video Journal of Hematology & HemOnc 0:59 2 years ago 745 Далее Скачать
Frontline, fixed-duration venetoclax/obinutuzumab: PFS and MRD data from CLL14 VJHemOnc – Video Journal of Hematology & HemOnc 1:12 5 years ago 115 Далее Скачать
Venetoclax plus obinutuzumab in CKT CLL: analysis from the CLL14 trial VJHemOnc – Video Journal of Hematology & HemOnc 1:24 5 years ago 264 Далее Скачать
Venetoclax-Obinutuzumab vs Chlorambucil-Obinutuzumab To Treat CLL CheckRare 7:32 4 years ago 273 Далее Скачать
Obinutuzumab and venetoclax for high-risk CLL: upcoming CLL14 trial VJHemOnc – Video Journal of Hematology & HemOnc 0:45 8 years ago 235 Далее Скачать
Time-limited venetoclax-obinutuzumab +/- ibrutnib surpasses CIT in frontline CLL ecancer 4:29 2 years ago 91 Далее Скачать
CLL14: Can we treat CLL without chemotherapy, venetoclax plus obinutuzumab ecancer 4:37 5 years ago 721 Далее Скачать
